Healthtech funding in December 2021
European Healthtech startup funding raised during December 2021.
In December 2021, 58 European Healthtech companies closed 58 funding rounds and raised €1.0B in equity funding (excluding debt and grants), up 224.3% versus December 2020. Debt rounds added €20M. Czech Republic led by capital raised, and Verve Ventures was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.0B
+224.3% vs December 2020 · excl. debt & grants · +€20M debt
Funding rounds
58
+45.0% vs December 2020
Companies
58
Top country
Czech Republic
Rank among sectors
#3
12.0% of sector funding
Debt financing
€20M
1.9% of total
Top-10 round share
75.2%
of disclosed capital
Rounds ≥ €100M
2
Top countries
by € raisedHealthtech — top countries by capital, December 2021 — interactive chart.
Data table
| Healthtech — top countries by capital, December 2021 | |
|---|---|
| Czech Republic | €280M |
| Netherlands | €144M |
| Switzerland | €131M |
| Germany | €123M |
| Belgium | €122M |
| UK | €87M |
| France | €73M |
| Sweden | €39M |
Stage mix
by € raisedHealthtech — stage mix, December 2021 — interactive chart.
Data table
| Healthtech — stage mix, December 2021 | |
|---|---|
| Other | €640M |
| Series B | €168M |
| Series A | €128M |
| Series C | €65M |
| Seed | €26M |
| Debt | €20M |
| Crowdfunding | €1.2M |
| Pre-Seed | €440k |
Top deals
largest disclosed rounds in December 2021| Company | Stage | Date | Amount |
|---|---|---|---|
| Sotio Biotech | Other | Dec 2021 | €280M |
| Anaveon | Series B | Dec 2021 | €105M |
| Emergence Therapeutics | Other | Dec 2021 | €87M |
| Northsea Therapeutics | Other | Dec 2021 | €71M |
| ViCentra | Series C | Dec 2021 | €65M |
| Adendra Therapeutics | Series A | Dec 2021 | €47M |
| EyeD Pharma | Other | Dec 2021 | €45M |
| Depixus | Series A | Dec 2021 | €31M |
| Bokadirekt | Other | Dec 2021 | €29M |
| Celyad Oncology | Other | Dec 2021 | €29M |
| Kenbi | Series A | Dec 2021 | €24M |
| Dawn Health | Other | Dec 2021 | €22M |
| FineHeart | Series B | Dec 2021 | €21M |
| Midiagnostics | Debt | Dec 2021 | €20M |
| Brainomix | Series B | Dec 2021 | €19M |
Top investors
most active in December 2021, by deal count- Verve Ventures3 deals
- Bpifrance2 deals
- EIT Health2 deals
- Flerie Invest2 deals
- Forbion2 deals
- MedTech Entrepreneurs2 deals
- Pontifax Funds2 deals
- Acton Capital Partners1 deals
- Advent France Biotechnology1 deals
- Akiles1 deals